Related Experiment Video
Updated: Feb 9, 2026

A Mouse Model for Laser-induced Choroidal Neovascularization
Published on: December 27, 2015
Effect of integrin α5β1 inhibition on SDF-l/CXCR4-mediated choroidal neovascularization
Yang Lyu1,2, Wen-Qin Xu1, Li-Juan Sun1
1Department of Ophthalmology, Eye Institute of China PLA, Xijing Hospital, the Fourth Military Medical University, Xi'an 710032, Shaanxi Province, China.
Aim:
To investigate the roles of integrins in choroidal neovascularization (CNV) and their associations with the stromal cell-derived factor-1 (SDF-1)/CXCR4 axis.
Methods:
CNV lesions were induced in mice using laser photocoagulation. After CNV induction, all animals were randomly assigned to: control, SDF-1, SDF-1+age-related macular degeneration (AMD) 3100 (CXCR4 inhibitor), and SDF-1+ATN161 (integrin α5β1 inhibitor) groups; their effects on CNV progression were observed using hematoxylin eosin (HE) staining, fundus fluorescein angiography (FFA) grading and optical coherence tomography (OCT), and their effects on CXCR4/integrin α5 expression were evaluated using Western blot and double immunofluorescence staining. Hypoxia-exposed endothelial cells (ECs) were used to simulate CNV in vitro, they were treated with SDF-1, combined with CXCR4 siRNA/AMD3100 or ATN161, and expression of integrin α5, cell migration and tube formation were analyzed.
Results:
Integrin subunit α5 increased at 3rd and 7th day and decreased at 14th day in CNV mice, with no significant change of β1-integrin. CXCR4 expression in CNV mice had persistent increase within 14d after induction. SDF-1 treatment significantly promoted the CNV progression during 3-14d. The mean CNV length in AMD3100 and ATN161 group at day 7 was 270.13 and 264.23 µm in HE images, significantly lower than the mean length in SDF-1 (345.70 µm) group. AMD3100 and ATN161 also significantly reduced thickness and leakage of CNV induced by SDF-1. Mean integrin α5 positive area in SDF-1 group reached 2.31×104 µm2, significantly higher than control (1.25×104 µm2), which decreased to 1.78×104 µm2 after AMD3100 treatment. About 61.36% of ECs in CNV lesions expressed α5 in SDF-1 group, which significantly decreased to 43.12% after AMD3100 treatment. In vitro, integrin α5 peaked by 6 folds after 6h of hypoxia exposure and CXCR4 gradually increased by up to 2.3 folds after 24h of hypoxia. Approximately 25.12% of ECs expressed integrin α5 after SDF-1 stimulation, which decreased to 7.2%-9.5% after si-CXCR4 or AMD3100 treatment. ATN161 exerted an inhibitory effect comparable to that of si-CXCR4 on EC migration and tube formation in the presence of SDF-1.
Conclusion:
SDF-1/CXCR4 signaling induces integrin α5β1 expression in ECs to promote CNV.
Insights
Stromal cell-derived factor-1 (SDF-1) and its receptor CXCR4 promote choroidal neovascularization (CNV) by increasing integrin α5β1 expression in endothelial cells. Inhibiting CXCR4 or integrin α5β1 effectively reduces CNV progression.
Area of Science:
- Ophthalmology
- Vascular Biology
- Cell Signaling
Background:
- Choroidal neovascularization (CNV) is a major cause of vision loss.
- The stromal cell-derived factor-1 (SDF-1)/CXCR4 axis and integrins are implicated in CNV pathogenesis.
Purpose of the Study:
- To investigate the role of integrins in CNV.
- To explore the association between integrins and the SDF-1/CXCR4 axis in CNV.
Main Methods:
- CNV was induced in mice using laser photocoagulation.
- Animals were treated with SDF-1, a CXCR4 inhibitor (AMD3100), or an integrin α5β1 inhibitor (ATN161).
- CNV progression was assessed using HE staining, FFA, and OCT; protein expression was analyzed via Western blot and immunofluorescence. In vitro studies used hypoxia-exposed endothelial cells.
Main Results:
- SDF-1 treatment significantly promoted CNV progression.
- Inhibitors of CXCR4 (AMD3100) and integrin α5β1 (ATN161) significantly reduced CNV size, thickness, and leakage.
- SDF-1 increased integrin α5 and CXCR4 expression in vivo and in vitro; AMD3100 and ATN161 treatments decreased these levels and inhibited endothelial cell migration and tube formation.
Conclusions:
- SDF-1/CXCR4 signaling drives CNV by upregulating integrin α5β1 expression in endothelial cells.
- Targeting the SDF-1/CXCR4 axis or integrin α5β1 presents a potential therapeutic strategy for CNV.
Related Concept Videos
Integrins
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
Activation of Integrins
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding...
Feedback Inhibition
Enzyme Inhibition
Inhibition of Cdk Activity
Receptor-mediated Endocytosis

